Events

Recall of ARCHITECT Free T4 Reagent. An in vitro diagnostic medical device (IVD)List Numbers: 7K65-29 (100 Test Kit), 7K65-34 (2000 Test Kit) and 7K65-39 (500 Test Kit)Multiple Lot Numbers (see attached)ARTG Number: 180112

According to Department of Health, Therapeutic Goods Administration, this recall involved a device in Australia that was produced by Abbott Australasia Pty Ltd Diagnostic Division.

What is this?

A correction or removal action taken by a manufacturer to address a problem with a medical device. Recalls occur when a medical device is defective, when it could be a risk to health, or when it is both defective and a risk to health.

Learn more about the data here
  • Type of Event
    Recall
  • Event ID
    RC-2017-RN-00562-1
  • Event Risk Class
    Class II
  • Event Initiated Date
    2017-05-02
  • Event Country
    Australia
  • Event Source
    DHTGA
  • Event Source URL
    https://apps.tga.gov.au/Prod/sara/arn-detail.aspx?k=RC-2017-RN-00562-1
  • Notes / Alerts
    Australian data is current through July 2018. All of the data comes from the Australian Therapeutic Goods Administration, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Australia.
  • Extra notes in the data
  • Reason
    Abbott diagnostics is providing information regarding a change of measuring interval for the architect free t4 assay list numbers 7k65-29, 7k65-34 and 7k65-39.The current measuring interval is 0.40 ng/dl (5.15 pmol/l) to 6.00 ng/dl (77.22 pmol/l).Recent data generated by abbott have determined that the measuring interval is 0.40 ng/dl (5.15 pmol/l) to 5.00 ng/dl (64.35 pmol/l). this new measuring range will be included in a future version of the instructions for use and the new ft4 assay file. there is no impact to patient results with values between 0.40 ng/dl (5.15 pmol/l) and 5.0 ng/dl (64.35 pmol/l). only the measuring interval between 5.00 – 6.00 ng/dl (64.35 – 77.22 pmol/l) is affected.
  • Action
    Abbott is advising users that patient sample results between 5.00 ng/dL (64.35 pmol/L) and 6.00 ng/dL (77.22pmol/L) should be reported as >5.00 ng/dL (64.35pmol/L). In addition, the customer letter should be reviewed with the laboratory’s management for potential impact specific to laboratory procedures such as internal ranges.

Device

ARCHITECT Free T4 Reagent. An in vitro diagnostic medical device (IVD)List Numbers: 7K65-29 (100 ...
  • Model / Serial
    ARCHITECT Free T4 Reagent. An in vitro diagnostic medical device (IVD)List Numbers: 7K65-29 (100 Test Kit), 7K65-34 (2000 Test Kit) and 7K65-39 (500 Test Kit)Multiple Lot Numbers (see attached)ARTG Number: 180112
  • Manufacturer
    Abbott Australasia Pty Ltd Diagnostic Division

Manufacturer

Abbott Australasia Pty Ltd Diagnostic Division
  • Manufacturer Parent Company (2017)
    Abbott Laboratories
  • Manufacturer comment
    “We are in constant communication with regulatory agencies and competent authorities worldwide which allows us to implement global recalls or in-country communication quickly and effectively,” Abbott, which now owns St. Jude Medical told ICIJ in a statement. In addition to sending global notices to physicians worldwide, we also make sure that product advisories are available online and classification of product recalls and product advisories are determined by global regulatory bodies which can impact the timing in any given country. MD companies follow varying regulations in different countries. In come countries software is not regulated so a recall in one country related to software would not be classified as a recall or field action in another. In addition, review cycles within the regulatory process can be different in each country which can impact communication and recall timing.
  • Source
    DHTGA